Features include Zeno SWATH DIA, stMRM, an integrated central console and accessibility across 9 languages

At ASMS 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches SCIEX OS software v3.0, a software ecosystem built on accessibility, connectivity and integration. With this launch, SCIEX OS software powers mass spectrometers across the SCIEX portfolio and enables the SCIEX ecosystem to deliver better quality data, boosted workflow efficiencies and comprehensive auditing advancements.

In addition to enabling Zeno SWATH DIA, also launched today, SCIEX OS software v3.0 features stMRM, a data rich, scout triggered MRM workflow. stMRM couples improved efficiency with better-quality data across vast screening workflows. It utilizes the intelligent monitoring of marker compounds to trigger the acquisition of later eluting dependent transitions to identify dependent compounds. stMRM removes analytical dependencies of chromatographic retention times allowing for improved cycle and dwell across compound transitions.

“Scout triggered MRM is being used at our institution to monitor 300 characteristic peptides in an 8 minute run-time, to specifically identify the pathogens concerned with sepsis. This research could start to impact patients in as little as 3 years,” said Jérôme Lemoine from Claude Bernard Lyon 1 University.

SCIEX OS software v3.0 brings laboratory administration to a new level of efficiency and comprehension with the launch of the Central Administration Console. This new feature brings project management, user profiles, permissions and security into a simple and navigable interface.

In addition, this launch improves accessibility to SCIEX systems with new language packs. Customers will now be able to operate SCIEX OS software in 9 languages: Chinese (simplified), English, French, German, Italian, Japanese, Korean, Portuguese and Spanish.

“Globally, customers have told us they need to be connected to their data. They need it to be readily accessible. They need software, free of barriers and obstacles that will evolve as their challenges evolve, and interpret data in a way that unlocks biological meaning. Connecting people to their pursuits and the pursuits of others is the inspiration for creating this unified software ecosystem,” said Joe Fox, President at SCIEX.

To learn more about SCIEX OS software v3.0, see www.sciex.com/sciexos.

About SCIEX

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have been at the forefront of the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, as part of the Danaher Corporation (NYSE:DHR) family of global science and technology companies, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers can quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.

Advances in human wellness depend on the power of precise science.

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

© 2022 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-14840-A.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005302/en/